Immatics Nv Stock Price on November 14, 2024
| IMTX Stock | USD 7.58 0.22 2.82% |
If you're considering investing in Immatics Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immatics stands at 7.58, as last reported on the 22nd of November, with the highest price reaching 8.04 and the lowest price hitting 7.58 during the day. Immatics NV holds Efficiency (Sharpe) Ratio of -0.2, which attests that the entity had a -0.2% return per unit of risk over the last 3 months. Immatics NV exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immatics' Market Risk Adjusted Performance of 1.11, standard deviation of 3.02, and Risk Adjusted Performance of (0.14) to validate the risk estimate we provide.
Immatics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Immatics |
Sharpe Ratio = -0.1989
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMTX |
Estimated Market Risk
| 3.02 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.6 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immatics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immatics by adding Immatics to a well-diversified portfolio.
Related Headline
Crinetics Pharmaceuticals Headline on 14th of November 2024
Crinetics Pharmaceuticals Announces Earnings Results, Misses... by thelincolnianonline.com
Crinetics Pharmaceuticals issued its quarterly earnings data on Tuesday. The company reported earnings per share for the quarter, missing the consensus estimate of by , Briefing.com reports. During the same period last year, the business posted EPS. Crinetics Pharmaceuticals Price Performance Shares of NASDAQ CRNX traded down
Immatics Valuation on November 14, 2024
It is possible to determine the worth of Immatics on a given historical date. On November 14, 2024 Immatics was worth 8.49 at the beginning of the trading date compared to the closed value of 8.53. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immatics stock. Still, in general, we apply an absolute valuation method to find Immatics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immatics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immatics' related companies.
| Open | High | Low | Close | Volume | |
| 8.56 | 8.78 | 8.41 | 8.57 | 1,114,297 | |
11/14/2024 | 8.49 | 8.81 | 8.32 | 8.53 | 839,174 |
| 8.53 | 8.67 | 7.94 | 8.17 | 1,172,696 |
| Backtest Immatics | | | Immatics History | | | Immatics Valuation | Previous | Next |
Immatics Trading Date Momentum on November 14, 2024
| On November 15 2024 Immatics NV was traded for 8.17 at the closing time. The top price for the day was 8.67 and the lowest listed price was 7.94 . The trading volume for the day was 1.2 M. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 4.22% . The trading delta at closing time against the current closing price is 8.56% . |
Immatics NV Fundamentals Correlations and Trends
By evaluating Immatics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immatics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immatics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immatics Stock history
Immatics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immatics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immatics NV will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immatics stock prices may prove useful in developing a viable investing in Immatics
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 388 people.
Immatics Stock Technical Analysis
Immatics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immatics Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Immatics NV cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Immatics November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Immatics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immatics shares will generate the highest return on investment. By undertsting and applying Immatics stock market strength indicators, traders can identify Immatics NV entry and exit signals to maximize returns
Immatics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immatics' price direction in advance. Along with the technical and fundamental analysis of Immatics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immatics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.56) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | 1.1 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Immatics Stock Analysis
When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.